Rx Data Portal Resources

Related Topics

Contact Info
Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Contact Info

Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Rx Data Portal Resources

This page provides resources to support entities submitting information to the Minnesota Department of Health (MDH) via the Rx Data Portal in their compliance with the Prescription Drug Price Transparency Act (Minnesota Statutes 62J.84) and the 340B Covered Entity Report (Minnesota Statutes 62J.461).

Using the Rx Data Portal

All entities and designated third party affiliates must use the Rx Data Portal to submit information to MDH under the Prescription Drug Price Transparency Act and 340B Covered Entity Report.  Here are technical guides for reporting entities to set up and manage their account. Please email health.rx@state.mn.us with any technical questions about using the portal.

See below for video tutorials customized to each reporting entity type.

Notice: Tutorial videos for the Rx Data Portal are currently being updated to reflect enhancements made to the portal in 2025. While updates are underway, some videos may not fully match the current portal experience. Updated tutorials will be posted soon. 

Customized support by entity type

340B covered entities in Minnesota are required to annually report data related to their 340B prescription drug purchases and payments. 

Video tutorial 

This video provides a step-by-step tutorial for navigating the Rx Data Portal as a 340B reporting entity.

Reporting guidance

Access the 340B Covered Entity Reporting Resources page for submission requirements and MDH guidance.

Drug manufacturers are required to report drug pricing information under the New Drug and Price Growth provisions of the Prescription Drug Price Transparency Act on a rolling basis and are required to report under the Drugs of Substantial Public Interest (PI) provision when new PI lists are published.

Video tutorials

The following video provides a step-by-step tutorial for navigating the Rx Data Portal to submit New Drug and Price Growth reports.

The following video provides a step-by-step tutorial for navigating the Rx Data Portal to submit PI list data as a manufacturer.

Reporting guidance

Access the Reporting Information for Manufacturers page for submission requirements and MDH guidance.

Wholesalers are required to report under the Drugs of Substantial Public Interest (PI) provision when new PI lists are published.

Video tutorial

This video provides a step-by-step tutorial for navigating the Rx Data Portal as a wholesaler.

Reporting guidance

Access the Reporting Information for Wholesalers page for submission requirements and MDH guidance.

Pharmacies are required to report under the Drugs of Substantial Public Interest (PI) provision when new PI lists are published. 

Video tutorial

This video provides a step-by-step tutorial for navigating the Rx Data Portal as a pharmacy.

Reporting Guidance

Access the Reporting Information for Pharmacies page for submission requirements and MDH guidance.

Pharmacy Benefit Managers (PBMs) are required to report under the Drugs of Substantial Public Interest (PI) provision when new PI lists are published. 

Video tutorial 

This video provides a step-by-step tutorial for navigating the Rx Data Portal as a PBM.

Reporting guidance

Access the Reporting Information for Pharmacy Benefit Managers page for submission requirements and MDH guidance.

Tags
Last Updated: 12/31/2025